UK researchers at the University of Exeter have identified an unprecedented genetic mutation present in two siblings, unseen in any other individuals. This finding opens avenues for novel treatment strategies in the realm of type 1 diabetes.
The mutation occurs within the gene responsible for encoding programmed death-ligand 1 (PD-L1) protein. A recent study elucidates how this mutation potentially triggers the autoimmune manifestation of diabetes observed in affected children from a very early age.
Matthew Johnson, a molecular geneticist from the University of Exeter in the UK, explains, “We scoured various large-scale datasets worldwide but haven’t encountered another family with similar genetic characteristics. Hence, these siblings offer a unique and profoundly significant opportunity to probe the consequences of PD-L1 gene disruption in humans.”
Type 1 diabetes, also referred to as autoimmune diabetes, arises due to the immune system’s erroneous attack on pancreatic beta cells, halting the normal production of insulin. Individuals afflicted with this condition must administer insulin injections regularly to regulate their blood sugar levels.
The siblings, aged 10 and 11 during the study, developed diabetes within the initial weeks of their lives. Subsequent examination of immune cells from the siblings corroborated that their distinctive genetic mutation impeded the proper functioning of the PD-L1 protein.
